Drug Interactions between daclatasvir and RibaPak
This report displays the potential drug interactions for the following 2 drugs:
- RibaPak (ribavirin)
Interactions between your drugs
No interactions were found between daclatasvir and RibaPak. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Ribapak is in the following drug classes: inhaled anti-infectives, purine nucleosides.
- Ribapak is used to treat Hepatitis C.
Drug and food interactions
Applies to: RibaPak (ribavirin)
Food can enhance the levels of ribavirin in your body. Ribavirin should be taken with food or just after eating. This will make it easier for your body to absorb the medication. Do not take it on an empty stomach. Swallow the tablet or capsule whole.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.